Clinical trials: Benign Hyperplasia of Prostate
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient
To determine if use of Moses 2.0 results in improved ablation efficiency during holmium laser vaporization of the prostate. To determine if use of Moses 2.0 results in less char, improved visibility, and improved hemostasis in…
- Trial name
- Moses 2 (NCT04979143)
- Testing
- Surgical Approach
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- University of Kansas Medical Center
Benign Prostatic Hyperplasia, Benign Prostatic Obstruction
Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation of the Prostate
Bipolar enucleation of the prostate is an effective operation for men with urinary obstruction caused by a benign enlarged prostate. Some men leak urine for a period after the operation.
- Conditions
- Benign Prostatic Hyperplasia, Benign Prostatic Obstruction, Stress Urinary Incontinence (SUI), Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
- Trial name
- ABPS-EAR-BIPO (NCT07893548)
- Testing
- Anterior Bridge-Preserving Semicircular Early Apical Release (ABP-S-EAR), Conventional Early Apical Release (EAR)
- Volunteers
- 230 people
- Sponsor
- Benha University
Benign Prostatic Hyperplasia
Kinetics of the Finasteride Prostate Induced Apoptosis
The aim of this study is to evaluate the mechanisms involved in the apoptosis induced by a treatment of finasteride on benign prostate hyperplasia (BPH).
- Trial name
- NCT00130767
- Testing
- finasteride
- Where
- France
- Volunteers
- 90 people
- Sponsor
- Hospices Civils de Lyon
Benign Prostatic Hyperplasia
Low Power ThULEP for Prostate Size More Than 80 gm
Feasibility and Efficacy of lower power thulium enucleation of prostate more than 80 grams
- Trial name
- NCT05494944
- Testing
- ThuLEP
- Where
- Egypt
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Kasr El Aini Hospital
Benign Prostatic Hyperplasia
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
Purpose: To evaluate the efficacy of prostatic artery embolization (PAE) in patients with benign prostatic hyperplasia (BPH) and refractory lower urinary tract symptoms (LUTS) in decreasing the volume of the prostate gland.
- Trial name
- NCT02167919
- Testing
- Microspheres
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- University of North Carolina, Chapel Hill
BPH
A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI
A total of up to 15 eligible subjects will be enrolled into this open-labeled one-arm study designed to observe the mechanism of action of iTind when using MRI
- Trial name
- NCT03994263
- Testing
- ITind device implant
- Where
- Germany
- Volunteers
- 1 people
- Sponsor
- Medi-Tate Ltd.
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPH
Benign prostatic hyperplasia (BPH) is a common non-cancerous enlargement of the prostate gland in aging men that causes bothersome lower urinary tract symptoms (LUTS), including frequent urination, weak urinary stream, and…
- Trial name
- NCT07904702
- Testing
- Prostatic Artery Embolization with N-butyl Cyanoacrylate
- Volunteers
- 30 people
- Sponsor
- Assiut University
Benign Prostatic Hyperplasia
BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia
The purpose of this study is to compare the UroLift System Treatment to Transurethral Resection of the Prostate (TURP) in improving a patient's overall quality of life, while evaluating healthcare expenditures associated with…
- Trial name
- BPH-6 (NCT01533038)
- Testing
- UroLift System, Transurethral Resection of the Prostate
- Where
- 9 sites in Denmark, Germany and 1 more
- Volunteers
- 80 people
- Sponsor
- NeoTract, Inc.
Benign Prostatic Hyperplasia
A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic Hyperplasia
This is a prospective, multicentre, non-interventional study, conducted in France and Spain, in primary care practices and designed to assess the QoL of patients under phytotherapy or alpha-blockers for LUTS/BPH.
- Trial name
- PERQoL (NCT07144709)
- Testing
- Phytotherapy
- Where
- 31 sites in France, Spain
- Volunteers
- 288 people
- Sponsor
- Pierre Fabre Medicament
Benign Prostatic Hyperplasia, Enlarged Prostate
Laser Prostatectomy Database and Registry
STATEMENT OF PURPOSE: Transurethral resection of the prostate (TURP) is the standard surgical intervention for obstructive benign prostatic hyperplasia (BPH) in all but the largest of glands, which are typically treated with open…
- Trial name
- NCT00159406
- Testing
- Registry and Database
- Where
- United States
- Volunteers
- 3,000 people
- Sponsor
- Indiana Kidney Stone Institute
Cardiovascular Disease, Diabetes
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
The aim of this study is to determine whether adherence to oral maintenance medications differs for patients randomized to receive a RxTimerCap, a Take-N-Slide, a standard pillbox, or none of these devices, with the hypothesis…
- Conditions
- Cardiovascular Disease, Diabetes, Breast Cancer, Depression
- Trial name
- REMIND (NCT02015806)
- Testing
- RxTimerCap, Take-N-Slide, Pillbox
- Where
- United States
- Volunteers
- 53,480 people
- Sponsor
- Brigham and Women's Hospital
Benign Prostatic Hyperplasia
Comparing Rezum and Urolift
This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.
- Trial name
- NCT06820606
- Testing
- Rezum, UroLift
- Where
- Hong Kong
- Volunteers
- 120 people
- Sponsor
- Chinese University of Hong Kong
Benign Prostatic Hyperplasia
Middle Lobe Only Laser Vaporization or Total Prostate Vaporization of the Prostate, Prospective Cohort Study
The investigator aims to prospectively investigate the efficacy and durability of the middle lobe only versus traditional complete photoselective greenlight vaporization of the prostate in patients with prominent middle lobe.
- Trial name
- NCT04529369
- Testing
- Middle lobe only Photoselective vaporization of the prostate (PVP), Complete PVP
- Volunteers
- 280 people
- Sponsor
- Jewish General Hospital
Benign Prostatic Hyperplasia
Comparison of Glue with Microparticles in Prostatic Artery Embolization
Prostatic artery embolisation (PAE) is an alternative treatment to surgery for benign prostatic hyperplasia (BPH). It has been practised since 2012 and numerous publications have proved not only its safety but also its efficacy.
- Trial name
- EMBOLICOL (NCT06678308)
- Testing
- Embolisation with Magic Glue®, Embolisation with Embosphere®
- Where
- France
- Volunteers
- 96 people
- Sponsor
- Almaviva Sante
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)
Benign prostatic hyperplasia (BPH), the non-malignant enlargement of the prostate gland, places pressure on the urethra and causes urination difficulties and bladder problems.
- Trial name
- NCT04391114
- Testing
- Traditional HoLEP, Top-Down HoLEP
- Where
- Canada
- Volunteers
- 107 people
- Sponsor
- Thunder Bay Regional Health Research Institute
Benign Prostatic Hyperplasia
Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
Prostate adenoma or benign prostatic hypertrophy (BPH) is a benign disease of the prostate gland. It results in an increase in the volume of the prostate area located in contact with the urethra.
- Trial name
- NCT04853914
- Testing
- HIFU treatment
- Where
- France
- Volunteers
- 9 people
- Sponsor
- EDAP TMS S.A.
Prostatic Hyperplasia, Benign
Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction
Rationale: With age a large group of men experience lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO). Standard treatment is a transurethral resection of the prostate or laser vaporization.
- Trial name
- NCT03653117
- Testing
- Transperineal laser ablation
- Where
- Netherlands
- Volunteers
- 20 people
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Benign Prostatic Hyperplasia (BPH), Overactive Bladder
Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overactive Bladder
This study will evaluate the efficacy of pelvic floor muscle training in men with benign prostatic hyperplasia and overactive bladder treated with Silodosin.
- Trial name
- SILODOSING (NCT04681625)
- Testing
- Pelvic floor muscle training (PFMT) with suppressive urgency technique
- Where
- Slovakia
- Volunteers
- 172 people
- Sponsor
- Comenius University
Benign Prostatic Hyperplasia (BPH)
HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study
Comparison in outcomes of a minimally invasive surgical modality (Holmium Laser Enucleation of Prostate) in management of voiding versus storage lower urinary tract symptoms associated with Benign Prostatic Hyperplasia
- Trial name
- NCT04178811
- Testing
- Holmium Laser Enucleation of Prostate
- Where
- Egypt
- Volunteers
- 132 people
- Sponsor
- Assiut University
Benign Prostatic Hyperplasia
Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands
The efficacy and safety of holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) have been comprehensively assessed.
- Trial name
- ExpHo (NCT03583034)
- Testing
- Holmium laser enucleation of the prostate (HoLEP)
- Where
- Italy
- Volunteers
- 275 people
- Sponsor
- IRCCS San Raffaele